切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Insulin and Insulin-like Receptors - 5-HT Transporters - TBK1 - KDM

11件产品中的 1-10

页面
每页
清除全部
  1. TC-E 5002
    B4930 TC-E 5002
    Target: KDM
    Summary: 选择性组蛋白去甲基化酶KDM2/7亚家族抑制剂
      Soluble in DMSO
  2. Paroxetine HCl
    B2252 Paroxetine HCl
     1 Citation
    中文名: 盐酸帕罗西汀
    Target: 5-HT Transporters
    Summary: 抗抑郁药
      ≥36.73 mg/mL
      insoluble in H2O
  3. Desvenlafaxine
    B2236 Desvenlafaxine
    中文名: 去甲文拉法辛
    Target: 5-HT Transporters|Norepinephrine transporters
    Summary: 5-羟色胺(5-HT)和去甲肾上腺素(NE)再摄取抑制剂
      ≥13.2 mg/mL
  4. Amitriptyline HCl
    B2231 Amitriptyline HCl
    中文名: 盐酸阿米替林
    Target: Trk Receptors|5-HT2 Receptors|Norepinephrine transporter|5-HT Transporters
    Summary: 血清素/去甲肾上腺素受体/5-HT4/5-HT2抑制剂
      ≥15.69 mg/mL
      ≥43.9 mg/mL
  5. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  6. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  7. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  8. MRT67307 HCl
    A3635 MRT67307 HCl
    Target: TBK1|MARK1|NUAK1
    Summary: SIK/TBK-1/IKKe抑制剂
      ≥23.25 mg/mL
      ≥52.5 mg/mL
  9. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: 胰高血糖素受体/ IGF-1R拮抗剂
      ≥24.05 mg/mL
      insoluble in H2O
  10. Daminozide
    A3348 Daminozide
    中文名: 丁酰肼
    Target: KDM|PHF
    Summary: KDM2A抑制剂
      ≥7.3 mg/mL
      ≥21.4 mg/mL

11件产品中的 1-10

页面
每页